All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

382

Reset

382 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • OH2Phase 36 trials

    Binhui Biopharmaceutical Co., Ltd. · Melanoma, Solid Tumor, Gastrointestinal Cancer

  • OlomorasibLY3537982Phase 36 trials

    Eli Lilly · Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Neoplasm Metastasis

  • Merck & Co. · Esophageal Squamous Cell Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma

  • tinengotinibTT-00420Phase 36 trials

    TransThera Sciences (Nanjing), Inc. · Prostate Cancer (CRPC), Cholangiocarcinoma, Hepatocellular Carcinoma (HCC)

  • GEMPhase 35 trials

    Shenzhen Majory Biotechnology Co., Ltd. · Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Cancer, Recurrent or Metastatic Cervical Cancer

  • GlumetinibSCC244Phase 35 trials

    Shanghai JMT-Bio Inc. · Non-Small Cell Lung Cancer, Recurrent or Metastatic NSCLC Patients With Classical EGFR Mutations Accompanied by MET Amplification or Overexpression, C-Met Exon 14 Mutation

  • HRS-7058Phase 35 trials

    Shandong Suncadia Medicine Co., Ltd. · KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment, Solid Tumors, Pancreatic Cancer

  • HydronidoneF351Phase 35 trials

    Beijing Continent Pharmaceutical Co, Ltd. · Liver Fibrosis, Chronic Hepatitis B With Hepatic Fibrosis, Liver Fibrosis in Chronic Hepatitis B

  • PetosemtamabMCLA-158, GEN1158Phase 35 trials

    Genmab · Head and Neck Squamous Cell Carcinoma, Colorectal Cancer, Advanced/Metastatic Solid Tumors

  • QLS31905Phase 35 trials

    Qilu Pharmaceutical Co., Ltd. · Advanced Solid Tumor, CLDN18.2-positive Advanced Biliary Tract Cancer, Gastric Adenocarcinoma

  • Saroglitazar MagnesiumPhase 35 trials

    Zydus Therapeutics Inc. · Primary Biliary Cholangitis, Nonalcoholic Steatohepatitis, Fibrosis

  • SHR-A1904Phase 35 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Biliary Tract Cancer, Advanced Solid Tumors

  • ALN-CIDEBPhase 34 trials

    Regeneron · Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis, MASLD

  • AtebimetinibIMM-1-104, Group APhase 34 trials

    Immuneering Corporation · Pancreatic Adenocarcinoma, Advanced Solid Tumor, Malignant Melanoma (Cutaneous)

  • CamlipixantBLU-5937Phase 34 trials

    GSK · Refractory Chronic Cough, Cough, Irritable Bowel Syndrome

  • DP303cPhase 34 trials

    CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · HER2-positive Breast Cancer, Advanced Solid Tumors, Localized Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

  • folinic acidPhase 34 trials

    Astellas · Unresectable Metastatic Colorectal Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer

  • GlepaglutideZP1848Phase 34 trials

    Zealand Pharma · Short Bowel Syndrome, Short Bowel Syndrome (SBS)

  • H2 receptor antagonistPhase 34 trials

    Merck & Co. · Lung Neoplasm Malignant, Esophageal Squamous Cell Carcinoma, Ovarian Cancer

  • HLX22Phase 34 trials

    Shanghai Henlius Biotech · HER2 + Breast Cancer, HER2-low Hormone Receptor Positive Breast Cancer, Gastroesophageal-junction Cancer

  • HTD1801Berberine UrsodeoxycholatePhase 34 trials

    Shenzhen HighTide Biopharmaceutical Ltd. · T2DM (Type 2 Diabetes Mellitus), Nonalcoholic Steatohepatitis (NASH), Type 2 Diabetes

  • IBI343Arcotatug TavatecanPhase 34 trials

    Innovent Biologics (Suzhou) Co. Ltd. · CLDN18.2 Positive, Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Primary Gastric Adenocarcinoma

  • JP-1366Phase 34 trials

    Onconic Therapeutics Inc. · H. Pylori Eradication Therapy, Non-erosive Gastroesophageal Reflux Disease, Maintenance of Healed Erosive Gastroesophageal Reflux Disease (ERD)

  • MaltodextrinPhase 34 trials

    RDC Clinical Pty Ltd · Muscle Pain, Chronic Inflammation, Mobility

  • NavlimetostatBMS-986504, MRTX1719Phase 34 trials

    Bristol Myers Squibb · Pancreatic Ductal Adenocarcinoma, Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Solid Tumors

  • PemvidutidePhase 34 trials

    Altimmune, Inc. · Alcohol-associated Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Alcohol Use Disorder (AUD)

  • zoldonrasibPhase 34 trials

    Revolution Medicines, Inc. · Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC

  • [18F]FAPI-74 PETPhase 33 trials

    SOFIE · Esophageal Cancer, Gastric Cancer (GC), Gastroesophageal Junction

  • ASKB589Phase 33 trials

    AskGene Pharma, Inc. · Gastric Cancer, Gastroesophageal Cancer (GC), Malignant Solid Tumor

  • BGB-B2033Phase 33 trials

    BeOne Medicines (BeiGene) · Liver Cancer, Hepatocellular Carcinoma, Hepatocellular Cancer

  • BrigimadlinBI 907828Phase 33 trials

    Boehringer Ingelheim · Solid Tumours, Pancreatic Neoplasms, Solid Tumors

  • CAM2029octreotide depotPhase 33 trials

    Camurus AB · Polycystic Liver Disease, Gastro-enteropancreatic Neuroendocrine Tumor, Acromegaly

  • ChiauranibCS2164Phase 33 trials

    Chipscreen Biosciences, Ltd. · Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Soft Tissue Sarcoma

  • coformulation favezelimabMK-4280APhase 33 trials

    Merck & Co. · Small Cell Lung Carcinoma, Solid Tumors, Hematologic Malignancies

  • DWP14012FexuprazanPhase 33 trials

    Daewoong Pharmaceutical Co. LTD. · Healed Erosive Esophagitis, Gastric Ulcer, Helicobacter Pylori Infection

  • EfruxiferminPhase 33 trials

    Akero Therapeutics, Inc · NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis, NASH/MASH

  • FluoropyrimidinePhase 33 trials

    Seattle Project Corporation · Colorectal Neoplasms, Gastric or Gastroesophageal Junction Adenocarcinoma, Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer

  • KC1036Phase 33 trials

    Beijing Konruns Pharmaceutical Co., Ltd. · Ewing Sarcoma, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma (ESCC)

  • Lutetium[177Lu] Oxodotreotidedotatate, 177Lu-DOTA0-Tyr3-OctreotatePhase 33 trials

    Sinotau Pharmaceutical Group · Gastroenteropancreatic Neuroendocrine Tumors, Pheochromocytoma, Paraganglioma

  • MaolactinPhase 33 trials

    RDC Clinical Pty Ltd · Muscle Pain, Chronic Inflammation, Mobility

  • ONO-4578Phase 33 trials

    Ono Pharmaceutical Co., Ltd. · Gastric Cancer, Esophagogastric Junction Cancer, Esophageal Adenocarcinoma

  • Oteracil Potassiumgimeracil], S-1 [TegafurPhase 33 trials

    AstraZeneca · Biliary Tract Cancer, Resectable Gastric/Gastroesophageal Junction Adenocarcinoma, Malignant Neoplasms of Digestive Organs

  • pegargiminaseADI-PEG 20Phase 33 trials

    Polaris Group · Glioblastoma Multiforme (GBM), Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma

  • PegozaferminBIO89-100Phase 33 trials

    Roche (Genentech) · Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Severe Hypertriglyceridemia

  • pulocimabAK109Phase 33 trials

    Akeso · Gastric and Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma, Advanced Solid Tumor

  • QuemliclustatPhase 33 trials

    Arcus Biosciences, Inc. · Metastatic Pancreatic Ductal Adenocarcinoma, Advanced Non-Small Cell Lung Cancer, Gastrointestinal Tract Malignancies

  • simmitinibPhase 33 trials

    Shanghai Runshi Pharmaceutical Technology Co., Ltd · Advanced Oesophageal Squamous Cell Carcinoma, Advanced Solid Tumor, Localized Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

  • SYHX2008Phase 33 trials

    CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Diagnosed With Acromegaly, Currently in the Active Stage of the Disease, Gastrointestinal Neuroendocrine Pancreatic Tumor, Acromegaly

  • VelzatinibGSK6042981Phase 33 trials

    GSK · Gastrointestinal Neoplasms, Gastrointestinal Stromal Neoplasms

  • 1.0% IP-001IP-001Phase 32 trials

    Immunophotonics, Inc. · Colorectal Cancer (CRC), Colon Cancer Liver Metastases, Rectal Cancer

NewerPage 2 of 8Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.